Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Meningioma × fludarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 167 Myelodysplastic Syndromes 111 Precursor Cell Lymphoblastic Leukemia-Lymphoma 107 Leukemia, Lymphocytic, Chronic, B-Cell 91 Leukemia 90 Lymphoma 78 Lymphoma, Non-Hodgkin 75 Multiple Myeloma 73 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60 Hodgkin Disease 59 Hematologic Neoplasms 59 Recurrence 45 Lymphoma, B-Cell 38 Myeloproliferative Disorders 36 Lymphoma, Mantle-Cell 36 Lymphoma, Follicular 34 Melanoma 31 Lymphoma, Large B-Cell, Diffuse 29 Burkitt Lymphoma 29 Graft vs Host Disease 25 Ovarian Neoplasms 23 Primary Myelofibrosis 22 Lymphoma, B-Cell, Marginal Zone 22 Neoplasms, Plasma Cell 19 Leukemia, Myelomonocytic, Chronic 19 Leukemia, Biphenotypic, Acute 17 Anemia, Refractory, with Excess of Blasts 17 Neuroblastoma 15 Lymphoma, T-Cell 15 Anemia, Aplastic 14

Interventions

Magnetic Resonance Spectroscopy 11 gallium Ga 68 dotatate 6 Everolimus 6 lutetium Lu 177 dotatate 5 Radiosurgery 5 Proton Therapy 5 pembrolizumab 4 Surveys and Questionnaires 4 Specimen Handling 4 Hydroxyurea 4 abemaciclib 3 Tranexamic Acid 3 Surgical Procedures, Operative 3 Ga(III)-DOTATOC 3 Bevacizumab 3 trametinib 2 arginyllysine 2 Yoga 2 Whole Body Imaging 2 Sunitinib 2 Sodium Chloride 2 Radiotherapy 2 Protons 2 Observation 2 Mental Status and Dementia Tests 2 Magnetic Resonance Imaging 2 Imatinib Mesylate 2 Gadolinium DTPA 2 Fluorodeoxyglucose F18 2 Filgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06640582 2024-11-05

BAH2472

Essen Biotech

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡